September 10, 2025BMJ OpenOpen Access

Pancreatic beta-cell secretory products in the diagnosis and risk stratification of gestational diabetes mellitus: a prospective longitudinal cohort study

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Prospective cohort study evaluates pancreatic beta-cell products' role in diagnosing gestational diabetes, suggesting C-peptide as a key indicator.

C-peptide levels significantly differed between groups, indicating its potential role in GDM diagnosis.
The study analyzed hormonal concentrations from 66 pregnant women, despite COVID-19 recruitment challenges.
Comparison of hormone levels revealed no significant difference in proinsulin and insulin across groups.
Results suggest further research is necessary to confirm findings in a larger cohort.

Dunseath et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

September 10, 2025BMJ OpenOpen Access

View Full Paper

Ask AI

Bookmark

Authors

Prospective cohort study evaluates pancreatic beta-cell products' role in diagnosing gestational diabetes, suggesting C-peptide as a key indicator.

C-peptide levels significantly differed between groups, indicating its potential role in GDM diagnosis.
The study analyzed hormonal concentrations from 66 pregnant women, despite COVID-19 recruitment challenges.
Comparison of hormone levels revealed no significant difference in proinsulin and insulin across groups.
Results suggest further research is necessary to confirm findings in a larger cohort.

Dunseath et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark